Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.45
-$0.03-6.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 41.55% | 187.90% | -19.84% | 244.71% | 72.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.88% | 56.90% | -25.71% | 163.75% | 113.11% |
| Operating Income | 24.88% | -56.90% | 25.71% | -163.75% | -113.11% |
| Income Before Tax | 29.50% | -63.58% | 37.97% | -82.48% | -76.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.50% | -63.58% | 37.97% | -82.48% | -76.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.50% | -63.58% | 37.97% | -82.48% | -76.37% |
| EBIT | 24.88% | -56.90% | 25.71% | -163.75% | -113.11% |
| EBITDA | 24.89% | -40.78% | 25.73% | -163.91% | -113.33% |
| EPS Basic | 94.37% | 88.37% | 97.36% | 86.36% | 63.57% |
| Normalized Basic EPS | 94.37% | 86.85% | 96.71% | 86.43% | 62.08% |
| EPS Diluted | 94.37% | 90.52% | 97.36% | 86.36% | 63.57% |
| Normalized Diluted EPS | 94.37% | 86.85% | 96.71% | 86.43% | 62.08% |
| Average Basic Shares Outstanding | 1,151.64% | 1,306.75% | 2,251.26% | 1,237.41% | 384.34% |
| Average Diluted Shares Outstanding | 1,151.64% | 1,306.75% | 2,251.26% | 1,237.41% | 384.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |